Related references
Note: Only part of the references are listed.A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma
Monique C. Tavares et al.
BMC CANCER (2021)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer
Javad Razaviyan et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
Ivana Zagorac et al.
NATURE COMMUNICATIONS (2018)
Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
Weikai Xiao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors
Amir Hossein Jafarian et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2018)
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer
Kai Wang et al.
HUMAN PATHOLOGY (2017)
ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism
Adi Y. Berman et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
J. M. Nabholtz et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert et al.
MODERN PATHOLOGY (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
Laura Mercatali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
Carlos A. Castaneda et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Tumor-infiltrating CD8+and FOXP3+lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
Minoru Miyashita et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
miR-15/16 complex targets p70S6 kinase1 and controls cell proliferation in MDA-MB-231 breast cancer cells
M. Janaki Ramaiah et al.
GENE (2014)
Triple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents
Prasanth Ganesan et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy
J. Sohn et al.
ANNALS OF ONCOLOGY (2013)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting p70S6K Prevented Lung Metastasis in a Breast Cancer Xenograft Model
Ugur Akar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C. A. Crane et al.
ONCOGENE (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
G Pérez-Tenorio et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
